• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials

Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials

by Marnie Willman | Dec 16, 2024 | Clinical Diagnostics Insider, Inside the Diagnostics Industry-dtet, Testing Trends-dtet

Learn how research and development labs can leverage AI to transform laboratory data into actionable insights

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
PGx Testing: First, Do No Harm

PGx Testing: First, Do No Harm

by Michael Schubert, PhD | Sep 20, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
OIG Greenlights Pharma Patient Assistance Arrangement

OIG Greenlights Pharma Patient Assistance Arrangement

by Glenn S. Demby | Mar 15, 2023 | News, Open Content

New Advisory Opinion 23-01 is similar to other arrangements the OIG has approved in the past.

New Urine Test Can Detect Synthetic Cannabinoids in Marijuana

New Urine Test Can Detect Synthetic Cannabinoids in Marijuana

by Glenn S. Demby | Nov 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Pharmacogenetic Testing Leads to Better Depression Treatment Decisions

Pharmacogenetic Testing Leads to Better Depression Treatment Decisions

by Glenn S. Demby | Oct 3, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com